[Levels of hyaluronic acid in chronic viral C hepatitis with relationship to liver steatosis].
Hialuronic acid, important element of extracellular matrix, plays a significant role in liver fibrosis. The aim of the work is to evaluate serum hialuronic acid concentrations in patients with chronic viral C hepatitis (CHC) and in patients with alcoholic liver steatosis in correlation with liver morphology and classic liver function tests. The study group consisted of 38 persons: 17 with CHC, including 8 with coexisting steatosis, 8 with alcohol liver steatosis and 13 healthy subjects as a controls. Hialuronic acid (HA) was measured in serum with the use of enzyme-linked binding protein assay, produced by Chugai Diagnostics Science Co., Japan. The highest mean HA concentration was found in CHC patients with steatosis (95.5 +/- 40.3 ng/ml) and it was significantly higher than among controls (56.9 +/- 17.8 ng/ml). The biggest necrosis and inflammation changes and fibrosis were observed in this group. HA concentration in alcoholic liver steatosis was insignificantly higher than among healthy controls (72.8 +/- 45.8 ng/ml). The lowest concentrations of HA were found in CHC patients without steatosis (32.9 +/- 9.8 ng/ml). There is correlation between serum HA concentration and liver fibrosis.